The establishment of a PRO-based adjuvant chemotherapy management system for patients with epithelial ovarian cancer

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300069160

Enrollment

Unknown

Registered

2023-03-08

Start date

2023-03-08

Completion date

Unknown

Last updated

2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer

Interventions

Case series:N/A

Eligibility

Sex/Gender

Female

Age

25 Years to 55 Years

Inclusion criteria

Inclusion criteria: The patients with epithelial cancer were underwent with postoperative adjuvant chemotherapy after radical surgery in early stage or cytoreductive surgery at advanced stage

Exclusion criteria

Exclusion criteria: The patiens with chemotherapy alone or the pathological type is non-epithelial

Design outcomes

Primary

Measure	Time frame
chemotherapy-related toxicities;	—

Secondary

Measure	Time frame
reliability;validity;	—

Countries

China

Contacts

Public ContactYing Tang

The affiliated Nanchong Central Hospital of North Sichuan Medical College

925393235@qq.com19960846866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026